Literature DB >> 2099196

HIV infection in sexually transmissible disease practice in Sydney: the effects of legislation, public education and changing clinical spectrum.

B Donovan1, R J Finlayson, K Mutimer, R Price, M Robertson, M Nelson, M Slade, I Reece, J dalle Nogare.   

Abstract

The experience with human immunodeficiency virus (HIV) infection of a private inner-city sexually transmissible diseases (STD) clinic in Sydney was quantified. Between February 1984 and March 1988, 2073 of the Clinic's patients were tested for antibodies to HIV on 5095 occasions. Of those tested, 538 (26%) were positive for antibodies to HIV: 532 (98.9%) of the seropositives had practised male homosexual intercourse. This is the highest reported seroprevalence of HIV for any primary care service in Australia. Those individuals seropositive because of other risk behaviours were detected by voluntary contact tracing rather than by screening. Female prostitution was not found to be a risk factor for HIV. In general, rates of first HIV antibody tests were adversely affected by threatening legislation, and temporarily stimulated (among lower-risk persons) by a national television campaign. These data suggest that much of the counselling, detection and management of HIV infection in Australia is occurring in private practice, and that STD services (private and public) are at the forefront of the HIV epidemic. This has implications for disease surveillance and control, health services planning and medical education.

Entities:  

Mesh:

Year:  1990        PMID: 2099196     DOI: 10.1177/095646249000100106

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Bullous impetigo in homosexual men--a risk marker for HIV-1 infection?

Authors:  B Donovan; R Rohrsheim; I Bassett; B P Mulhall
Journal:  Genitourin Med       Date:  1992-06

2.  A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis.

Authors:  Matt Shields; Rebecca J Guy; Neisha J Jeoffreys; Robert J Finlayson; Basil Donovan
Journal:  BMC Infect Dis       Date:  2012-12-17       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.